← Back to home

PERINATAL AND NEONATAL OUTCOMES IN PREGNANCIES WITH TYPE 2 DIABETES MELLITUS (T2DM)

Clinical trials for PERINATAL AND NEONATAL OUTCOMES IN PREGNANCIES WITH TYPE 2 DIABETES MELLITUS (T2DM) explained in plain language.

Never miss a new study

Get alerted when new PERINATAL AND NEONATAL OUTCOMES IN PREGNANCIES WITH TYPE 2 DIABETES MELLITUS (T2DM) trials appear

Sign up with your email to follow new studies for PERINATAL AND NEONATAL OUTCOMES IN PREGNANCIES WITH TYPE 2 DIABETES MELLITUS (T2DM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New supplement trial aims to protect babies from diabetes complications

Disease control Recruiting now

This is a small pilot study to see if a supplement called myo-inositol can help improve health outcomes for babies born to mothers with Type 2 Diabetes. It will recruit 182 pregnant women in Singapore to test if taking the supplement alongside standard care leads to healthier bir…

Matched conditions: PERINATAL AND NEONATAL OUTCOMES IN PREGNANCIES WITH TYPE 2 DIABETES MELLITUS (T2DM)

Phase: NA • Sponsor: National University Hospital, Singapore • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

PERINATAL AND NEONATAL OUTCOMES IN PREGNANCIES WITH TYPE 2 DIABETES MELLITUS (T2DM)

Get alerted when new PERINATAL AND NEONATAL OUTCOMES IN PREGNANCIES WITH TYPE 2 DIABETES MELLITUS (T2DM) trials appear

New supplement trial aims to protect babies from diabetes complications